161778-01-4Relevant articles and documents
Thromboxane modulating agents. 4. Design and synthesis of 3-(2-[{(4- chlorophenyl)sulfonyl}-amino]ethyl)benzenepropanoic acid derivatives as potent thromboxane receptor antagonists
Dack, Kevin N.,Dickinson, Roger P.,Long, Clive J.,Steele, John
, p. 2061 - 2066 (2007/10/03)
The design of a series of thromboxane receptor antagonists based on 3- (2-[{(4-chlorophenyl)sulfonyl}amino]ethyl)benzenepropanoic acid (1) is described. Addition of an arylmethyl group at the 5-position of 1 gave exceptionally potent agents in vitro and in vivo, with 13a (UK-147,535) giving complete blockade of the TxA2 receptor for greater than 12 hours in dogs, following an oral dose of 0.1 mg/kg.
BENZENEALKANOIC ACIDS FOR CARDIOVASCULAR DISEASES
-
, (2008/06/13)
Compounds of formula (I) wherein R 1, R 2, R 3 and R 4 are each H or C 1-C 4 alkyl; R 5 is (CH 2) m NHSO. sub.2 R 6 or (CH) m NHCOR 6 ; R 6 is C 1-C 6 alkyl, C 3-C 6 cycloalkyl optionally substituted by aryl, aryl or heteroaryl; R 7 is H, C 1-C 4 alkyl, C